High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.

MLA

Deenik, W., et al. “High-vs Low-Dose Cytarabine Combined with Interferon Alfa in Patients with First Chronic Phase Chronic Myeloid Leukemia. A Prospective Randomized Phase III Study.” Annals of Hematology, vol. 86, no. 2, Feb. 2007, pp. 117–25. EBSCOhost, https://doi.org/10.1007/s00277-006-0186-1.

APA

Deenik, W., van der Holt, B., Verhoef, G. E. G., Schattenberg, A. V. M. B., Verdonck, L. F., Daenen, S. M. G. J., Zachée, P., Westveer, P. H. M., Smit, W. M., Wittebol, S., Schouten, H. C., Löwenberg, B., Ossenkoppele, G. J., Cornelissen, J. J., Zachée, P., & Löwenberg, B. (2007). High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study. Annals of Hematology, 86(2), 117–125. https://doi.org/10.1007/s00277-006-0186-1

Chicago

Deenik, W., B. van der Holt, G. E. G. Verhoef, A. V. M. B. Schattenberg, L. F. Verdonck, S. M. G. J. Daenen, P. Zachée, et al. 2007. “High-vs Low-Dose Cytarabine Combined with Interferon Alfa in Patients with First Chronic Phase Chronic Myeloid Leukemia. A Prospective Randomized Phase III Study.” Annals of Hematology 86 (2): 117–25. doi:10.1007/s00277-006-0186-1.